GSK Gets A Lucky Q1 Boost, But All Eyes Are On RSV Vaccine Readout

Revenues Up By 32%

 
• By Andrew McConaghie
  
GSK Skyline
GlaxoSmithKline will spin out its consumer health division in July - by which time its RSV vaccine results should also be ready. • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip